Abstract:PurposeStage pT1 urothelial bladder cancer (UBC) is characterized as a challenging subentity of urothelial carcinoma with an unforeseeable clinical course. In addition to more or less established clinical and histopathological features, we evaluated the role of epithelial–mesenchymal transition (EMT) marker E-cadherin, shown to be of prognostic value in muscle-invasive disease, regarding the prognosis of stage pT1 high-grade (hg) UBC.MethodsTissue of 226 stage pT1 hg UBC patients from transurethral resection could be immunostained for E-cadherin. Kaplan–Meier analysis and univariate and multivariate Cox regression analyses regarding progression-free (PFS) and cancer-specific survival (CSS) were performed.ResultsAberrant expression of E-cadherin was recognized in 74% of patients. Kaplan–Meier analysis showed that aberrant E-cadherin expression was associated with worse 10-year PFS (62 vs. 90%, p = 0.045). In univariate analysis, aberrant E-cadherin staining, associated carcinoma in situ, grading 3 after WHO classification 1973 and infiltrative growth pattern at the invasion front were the statistically significant predictive factors for worse PFS, only infiltrative growth pattern for CSS. With regard to progression, grading 3 after WHO classification of 1973 (HR 6.49; CI 1.54–27.28, p = 0.011) and infiltrative tumor invasion pattern (HR 2.06; CI 1.10–3.86, p = 0.024) revealed as independent factors for PFS, and there was a trend also for E-cadherin expression (HR 0.45; CI 0.19–1.06; p = 0.068). Regarding CSS, infiltrative tumor growth pattern (HR 3.79; CI 1.67–8.60, p = 0.001) was the only statistically significantly independent predictive factor in multivariate Cox regression analysis.ConclusionsBeside invasion growth pattern and WHO grading 1973 that achieved to be independent prognostic factors, there was a trend for the parameter E-cadherin expression to be of predictive value for PFS in stage pT1 hg urothelial bladder carcinoma after organ-sparing approach. Further studies on genetic level are warranted to define the distinct role of EMT in early-invasive UBC.

The Prognostic Value of P-cadherin in Non-Muscle-invasive Bladder Cancer

Expression of N-cadherin Protein in Urothelial Bladder Cancer and Its Relation to Prognosis

Breast cancer prognosis and P-cadherin expression: systematic review and study-level meta-analysis

Prognostic Value of Serum P-cadherin Level in Patients with Non-Small Cell Lung Cancer

[Analysis of N-E cadherin switch as an independent predictive parameter of bladder cancer survival outcomes].

Predictive Value of Cadherin-11 for Subsequent Recurrence and Progression in Non-Muscle Invasive Bladder Cancer.

N-cadherin and P-cadherin Are Biomarkers for Invasion, Metastasis, and Poor Prognosis of Gallbladder Carcinomas.

Reduced E-cadherin Expression As a Prognostic Factor in Non-Muscle-invasive Bladder Cancer: A Systematic Review and Meta-Analysis

Clinical Significance of T-Cadherin Tissue Expression in Patients with Bladder Transitional Cell Carcinoma

The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.

Expression of E-, P- and N-Cadherin and Its Clinical Significance in Cervical Squamous Cell Carcinoma and Precancerous Lesions

Expression of E-Cadherin and Α-Catenin in Bladder Transitional Cell Carcinoma and Its Clinical Significance

E-Cadherin Promoter Polymorphism (C-160a) And Risk Of Recurrence In Patients With Superficial Bladder Cancer

Prognostic Value and Clinicopathological Significance of Epithelial Cadherin Expression in Non-Small Cell Lung Cancer.

The expression of E-cadherin protein in transitional cell cancer of bladder and its significance

WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach

Expression and clinical significance of E-cadherin-catenin complex in human transitional cell carcinoma of bladder

Expressions of E-cadherin and β-Catenin as Prognostic Factors in Stage Ⅲa Non-Small-Cell Lung Carcinoma

Transcriptome analysis of low-risk and high-risk non-muscular invasive bladder cancer patients to reveal disease progression related genes.

Prognostic Implication of Urothelial Stem Cell Markers Differs According to Primary Tumour Location in Non-Muscle-Invasive Bladder Cancer

Diagnostic and Prognostic Significance of E-cadherin and Ki-67 Expression in Non-Small Cell Lung Cancer Patients.